SAN CARLOS, Calif., May 23, 2006 (BUSINESS WIRE) -- Nektar Therapeutics (Nasdaq:NKTR) announced that it will Webcast its 2006 Annual Meeting of Stockholders on Thursday, June 1, 2006 beginning at 10:00 a.m. Pacific time. The presentation can be accessed on the investor relations page at www.nektar.com and will be available for replay until June 15, 2006.
Nektar Therapeutics is a biopharmaceutical company that develops and enables high-value, differentiated therapeutics with its industry-leading drug delivery technologies and expertise. The world's top biotechnology and pharmaceutical companies are developing new and better therapeutics using Nektar's advanced technologies and know-how. Nektar also develops its own products by applying its drug delivery technologies and its expertise to existing medicines to enhance performance, such as improving efficacy, safety and compliance.
SOURCE: Nektar Therapeutics
Nektar Therapeutics Joyce Strand, 650-631-3138 Jennifer Ruddock, 650-631-4954
Copyright Business Wire 2006
News Provided by COMTEX